emocha

Target SDGs

Target Users (Target Impact Group)

Public Sector Agencies, NGOs

Distributors / Implementing Organizations

Implementing organizations and partners:

• Maryland Innovation Initiative
• BioHealth Innovation
• Kapor Capital
• NIH - National Institute of Drug Abuse
• NIH - National Institute on Minority Health and Health Disparities
• SBIR - STTR

Manufacturing/Building Method

N/A

Intellectural Property Type

Copyright

User Provision Model

Users can download the app for free in Google Play.

Distributions to Date Status

10,000+ app installs according to Google Play as of 2020.

Design Specifications

eMocha is a smartphone application that allows patients to indicate symptoms and record themselves taking their medication. The patient can then securely submit this information to the eMocha server, where a clinician can then observe and confirm medication adherence using the eMocha web interface. The system also includes a notifications feature to remind patients to take their medication and inform providers about important patient-reported events. The app can be accessed from the Play Store for users while implementing organization have access to a web interface where they can monitor patient data. The app allows for:

• Dose-by-dose tracking using video Directly Observed Therapy (DOT).
• Patient-doctor communication.

Product Schematics

Technical Support

Provided by the manufacturer.

Replacement Components

N/A

Lifecycle

N/A

Manufacturer Specified Performance Parameters

eMocha seeks to enforce dose by dose adherence, amplify the patient engagement, focus resources, reduce costs, and improve outcomes.

Vetted Performance Status

eMocha has been implemented in Harris County (TX) and Baltimore (MD). Data is actively being gathered on usability, patient adherence, and cost savings at four Maryland health departments with support from an NIH grant. miDOT is also being used in an adherence-related study of Hepatitis C Virus in Denver, CO. miDOT will soon be tested in Pune and Bangalore, India. In a National Institute of Minority Health and Health Disparities Small Business Innovation Research grant across 3 Maryland public health departments, 100% of patients successfully completed tuberculosis treatment.

Safety

No known safety hazards are related to this product.

Complementary Technical Systems

N/A

Academic Research and References

Compliance with regulations

HIPAA-compliant mobile app. emocha also integrates with existing Electronic Medical Record (EMR) systems using XML medical data format.

Evaluation methods

Solution tested by partner organizations: Pathway Healthcare case studies for opioid use disorder Harris County, Texas has used emocha for active and latent TB treatment with over 400 patients since 2014 Massachusetts General Hospital case studies for HCV treatment Baltimore City, Philadelphia, and Washington, D.C. case studies for HIV and PrEP treatments

Other Information

Case studies. Emocha was awarded the Small Business Innovation Research (SBIR) award by NIH.